PFE – Pfizer Inc.
Pfizer, Inc.PFE
$27.73Name : Pfizer, Inc.
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $157,664,673,792.00
EPSttm : 1.36
Pfizer, Inc.
$27.73
0.43%$0.12Float Short %
2.52
Margin Of Safety %
25
Put/Call OI Ratio
0.93
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
-0.15
Price
27.71
Target Price
28.57
Analyst Recom
2.39
Performance Q
13.69
Relative Volume
0.75
Beta
0.44
Ticker: PFE
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-13 | PFE | 25.08 | 0.77 | 0.94 | 3240939 |
| 2026-01-14 | PFE | 25.58 | 0.78 | 0.31 | 3302518 |
| 2026-01-15 | PFE | 25.85 | 0.77 | 0.46 | 3335821 |
| 2026-01-16 | PFE | 25.66 | 0.77 | 0.49 | 3359201 |
| 2026-01-20 | PFE | 25.5 | 0.93 | 0.47 | 2541689 |
| 2026-01-21 | PFE | 25.91 | 0.92 | 0.33 | 2619040 |
| 2026-01-22 | PFE | 26.11 | 0.90 | 0.04 | 2656844 |
| 2026-01-23 | PFE | 25.64 | 0.92 | 0.64 | 2638553 |
| 2026-01-26 | PFE | 25.88 | 0.90 | 0.45 | 2586977 |
| 2026-01-27 | PFE | 26.48 | 0.89 | 0.21 | 2629820 |
| 2026-01-28 | PFE | 25.89 | 0.88 | 0.29 | 2674273 |
| 2026-01-29 | PFE | 26.08 | 0.89 | 0.30 | 2685863 |
| 2026-01-30 | PFE | 26.39 | 0.88 | 0.31 | 2699239 |
| 2026-02-02 | PFE | 26.65 | 0.91 | 0.60 | 2596031 |
| 2026-02-04 | PFE | 26.77 | 0.91 | 0.31 | 2721411 |
| 2026-02-05 | PFE | 26.47 | 0.89 | 0.81 | 2735080 |
| 2026-02-06 | PFE | 27.22 | 0.92 | 0.52 | 2770929 |
| 2026-02-09 | PFE | 27.03 | 0.92 | 0.47 | 2727746 |
| 2026-02-10 | PFE | 27.59 | 0.92 | 0.47 | 2752304 |
| 2026-02-11 | PFE | 27.72 | 0.93 | 0.15 | 2776236 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-13 | PFE | 25.08 | -10.0 | 9110.3 | 3.12 |
| 2026-01-14 | PFE | 25.59 | -10.2 | 9509.8 | 3.12 |
| 2026-01-15 | PFE | 25.88 | -10.2 | 9418.5 | 3.12 |
| 2026-01-16 | PFE | 25.67 | -11.1 | 9090.8 | 3.12 |
| 2026-01-20 | PFE | 25.50 | -10.2 | 9136.7 | 3.12 |
| 2026-01-21 | PFE | 25.91 | -10.2 | 9475.3 | 3.12 |
| 2026-01-22 | PFE | 26.14 | -10.2 | 9385.7 | 3.12 |
| 2026-01-23 | PFE | 25.65 | -10.2 | 9217.8 | 3.12 |
| 2026-01-26 | PFE | 25.86 | -10.2 | 9632.6 | 3.12 |
| 2026-01-27 | PFE | 26.48 | -10.2 | 9603.2 | 3.12 |
| 2026-01-28 | PFE | 25.89 | -9.8 | 8855.5 | 3.12 |
| 2026-01-29 | PFE | 26.09 | -9.8 | 9373.4 | 3.12 |
| 2026-01-30 | PFE | 26.45 | -9.8 | 9446.3 | 3.12 |
| 2026-02-02 | PFE | 26.65 | -9.8 | 9355.6 | 3.12 |
| 2026-02-03 | PFE | 25.73 | -9.8 | 8665.8 | 3.12 |
| 2026-02-04 | PFE | 26.77 | -9.8 | 9853.4 | 3.12 |
| 2026-02-05 | PFE | 26.48 | -20.6 | 9048.9 | 2.98 |
| 2026-02-06 | PFE | 27.21 | -20.6 | 9670.7 | 2.98 |
| 2026-02-09 | PFE | 27.02 | -20.9 | 8022.7 | 2.98 |
| 2026-02-10 | PFE | 27.59 | -20.9 | 8444.3 | 2.97 |
| 2026-02-11 | PFE | 27.71 | -21.2 | 8190.2 | 2.97 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-13 | PFE | 0.00 | -0.32 | 2.29 |
| 2026-01-14 | PFE | 0.00 | -0.32 | 2.29 |
| 2026-01-15 | PFE | 0.00 | -0.32 | 2.29 |
| 2026-01-16 | PFE | 0.00 | -0.32 | 2.29 |
| 2026-01-20 | PFE | 0.00 | -0.50 | 2.29 |
| 2026-01-21 | PFE | 0.00 | -0.50 | 2.29 |
| 2026-01-22 | PFE | 0.00 | -0.50 | 2.35 |
| 2026-01-23 | PFE | 0.00 | -0.50 | 2.35 |
| 2026-01-26 | PFE | 0.00 | 0.05 | 2.29 |
| 2026-01-27 | PFE | 0.00 | 0.05 | 2.29 |
| 2026-01-28 | PFE | 0.00 | 0.05 | 2.29 |
| 2026-01-29 | PFE | 0.00 | 0.05 | 2.29 |
| 2026-01-30 | PFE | 0.00 | 0.05 | 2.29 |
| 2026-02-02 | PFE | 0.00 | -0.36 | 2.29 |
| 2026-02-03 | PFE | 0.00 | -0.36 | 2.29 |
| 2026-02-04 | PFE | 0.00 | -0.36 | 2.29 |
| 2026-02-05 | PFE | 0.00 | -0.36 | 2.29 |
| 2026-02-06 | PFE | 0.00 | -0.36 | 2.29 |
| 2026-02-09 | PFE | 0.00 | 0.16 | 2.29 |
| 2026-02-10 | PFE | 0.00 | 0.16 | 2.29 |
| 2026-02-11 | PFE | 0.00 | 0.16 | 2.52 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
0.72
Avg. EPS Est. Next Quarter
0.72
Insider Transactions
Institutional Transactions
0.16
Beta
0.44
Average Sales Estimate Current Quarter
13885
Average Sales Estimate Next Quarter
14468
Fair Value
34.72
Quality Score
85
Growth Score
51
Sentiment Score
88
Actual DrawDown %
55.1
Max Drawdown 5-Year %
-59
Target Price
28.57
P/E
20.46
Forward P/E
9.83
PEG
P/S
2.52
P/B
1.7
P/Free Cash Flow
15.2
EPS
1.36
Average EPS Est. Cur. Y
2.97
EPS Next Y. (Est.)
2.82
Target Price Estimates Raised
Target Price Estimates Lowered
1
Profit Margin
12.38
Relative Volume
0.75
Return on Equity vs Sector %
-17.3
Return on Equity vs Industry %
-25.6
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.02
EBIT Estimation
8190.2
Pfizer, Inc.Sector: Healthcare
Industry: Drug Manufacturers - General
Employees:
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. has strategic collaboration with Boltz, PBC to develop and deploy state-of-the-art biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
stock quote shares PFE – Pfizer Inc. Stock Price stock today
news today PFE – Pfizer Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PFE – Pfizer Inc. yahoo finance google finance
stock history PFE – Pfizer Inc. invest stock market
stock prices PFE premarket after hours
ticker PFE fair value insiders trading